Suraksha Diagnostic Limited (BOM:544293)
India · Delayed Price · Currency is INR 277.10
-2.85 (-1.02%)
At close: Jun 5, 2026
Suraksha Diagnostic Revenue
In the fiscal year ending March 31, 2026, Suraksha Diagnostic had annual revenue of 3.10B INR with 23.13% growth. Suraksha Diagnostic had revenue of 814.12M in the quarter ending March 31, 2026, with 31.17% growth.
Revenue
3.10B
Revenue Growth
+23.13%
P/S Ratio
4.62
Revenue / Employee
2.39M
Employees
1,300
Market Cap
14.33B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 3.10B | 583.21M | 23.13% |
| Mar 31, 2025 | 2.52B | 333.84M | 15.26% |
| Mar 31, 2024 | 2.19B | 285.75M | 15.03% |
| Mar 31, 2023 | 1.90B | -330.59M | -14.81% |
| Mar 31, 2022 | 2.23B | 831.87M | 59.42% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Thyrocare Technologies | 8.29B |
| One Global Service Provider | 4.99B |
| Chandan Healthcare | 2.81B |
| Star Imaging and Path Lab | 885.27M |
| Modern Diagnostic & Research Centre | 814.48M |
| Invicta Diagnostic | 330.42M |
| Aspira Pathlab & Diagnostics | 249.82M |
| Clinitech Laboratory | 96.79M |